Express Scripts Holding Company (NASDAQ:ESRX) had its price objective raised by stock analysts at Morgan Stanley from $52.00 to $57.00 in a research note issued to investors on Thursday. The firm currently has an “underweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential downside of 5.49% from the company’s current price.

Several other research firms have also commented on ESRX. Cowen and Company reiterated an “outperform” rating and issued a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. BidaskClub downgraded shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Evercore ISI reduced their price objective on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th. Mizuho reduced their price objective on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Finally, Robert W. Baird reduced their price objective on shares of Express Scripts Holding from $73.00 to $53.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Four equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $71.17.

Express Scripts Holding (ESRX) traded down 1.47% on Thursday, reaching $60.30. 4,307,052 shares of the company’s stock were exchanged. The company has a market cap of $34.83 billion, a P/E ratio of 10.47 and a beta of 0.90. Express Scripts Holding has a 12-month low of $57.80 and a 12-month high of $77.61. The firm has a 50 day moving average of $62.96 and a 200-day moving average of $64.58.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the business earned $1.57 earnings per share. Equities analysts expect that Express Scripts Holding will post $6.99 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) PT Raised to $57.00 at Morgan Stanley” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/10/express-scripts-holding-company-esrx-pt-raised-to-57-00-at-morgan-stanley.html.

In other Express Scripts Holding news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the transaction, the vice president now owns 11,108 shares of the company’s stock, valued at $667,368.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.68% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Park National Corp OH increased its position in Express Scripts Holding by 0.3% in the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares in the last quarter. Parkside Financial Bank & Trust increased its position in Express Scripts Holding by 0.3% in the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after buying an additional 23 shares in the last quarter. Carroll Financial Associates Inc. increased its position in Express Scripts Holding by 1.0% in the second quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after buying an additional 30 shares in the last quarter. CAPROCK Group Inc. increased its position in Express Scripts Holding by 0.9% in the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after buying an additional 33 shares in the last quarter. Finally, Honkamp Krueger Financial Services Inc. increased its position in Express Scripts Holding by 0.8% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock worth $304,000 after buying an additional 38 shares in the last quarter. 90.20% of the stock is currently owned by institutional investors.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.